The present invention generally relates to suspension compositions having acarboxyvinylpolymer such as a carbomer, a galactomannan such as guar, and a boratecompound. Asparingly soluble particulate compound such as nepafenac is also included inthecompositions. In some embodiments, the sparingly soluble particulate compoundhas a smallparticle size to enhance bioavailability of the compound.